Bonstein Sara's most recent trade in Insmed Inc was a trade of 35,583 Common Stock done at an average price of $95.7 . Disclosure was reported to the exchange on July 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.66 per share. | 07 Jul 2025 | 35,583 | 106,198 (0%) | 0% | 95.7 | 3,403,870 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2025 | 23,565 | 15,710 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.43 per share. | 07 Jul 2025 | 23,565 | 128,064 (0%) | 0% | 26.4 | 622,823 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 96.19 per share. | 07 Jul 2025 | 22,181 | 84,017 (0%) | 0% | 96.2 | 2,133,590 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2025 | 13,717 | 12,023 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.46 per share. | 07 Jul 2025 | 13,717 | 141,781 (0%) | 0% | 26.5 | 362,952 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.74 per share. | 07 Jul 2025 | 6,244 | 100,137 (0%) | 0% | 19.7 | 123,257 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2025 | 6,244 | 18,880 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2025 | 4,362 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.70 per share. | 07 Jul 2025 | 4,362 | 104,499 (0%) | 0% | 24.7 | 107,741 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.71 per share. | 23 Jun 2025 | 49,104 | 102,197 (0%) | 0% | 101.7 | 4,994,368 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.95 per share. | 23 Jun 2025 | 35,253 | 138,665 (0%) | 0% | 18.9 | 668,044 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2025 | 35,253 | 99,007 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2025 | 12,636 | 25,124 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.74 per share. | 23 Jun 2025 | 12,636 | 151,301 (0%) | 0% | 19.7 | 249,435 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 102.15 per share. | 23 Jun 2025 | 8,661 | 93,536 (0%) | 0% | 102.1 | 884,721 | Common Stock |
| Xilio Therapeutics Inc | Sara M. Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 31,000 | 31,000 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.95 per share. | 10 Jun 2025 | 24,150 | 137,438 (0%) | 0% | 19.0 | 457,643 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 24,150 | 134,260 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. | 10 Jun 2025 | 23,740 | 161,178 (0%) | 0% | 17.1 | 405,242 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 23,740 | 35,610 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.99 per share. | 10 Jun 2025 | 20,926 | 125,665 (0%) | 0% | 89.0 | 1,862,205 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 89.85 per share. | 10 Jun 2025 | 15,825 | 109,840 (0%) | 0% | 89.8 | 1,421,876 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.29 per share. | 10 Jun 2025 | 7,310 | 146,591 (0%) | 0% | 88.3 | 645,400 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.12 per share. | 10 Jun 2025 | 7,277 | 153,901 (0%) | 0% | 87.1 | 633,972 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.93 per share. | 10 Jun 2025 | 6,328 | 103,512 (0%) | 0% | 90.9 | 575,405 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 91.66 per share. | 10 Jun 2025 | 100 | 103,412 (0%) | 0% | 91.7 | 9,166 | Common Stock |
| scPharmaceuticals Inc | Sara M. Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 71.50 per share. | 03 Jun 2025 | 1,579 | 113,288 (0%) | 0% | 71.5 | 112,899 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 31,610 | 31,610 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 6,508 | 114,867 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 67.81 per share. | 13 May 2025 | 8,870 | 109,993 (0%) | 0% | 67.8 | 601,475 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.61 per share. | 13 May 2025 | 1,634 | 108,359 (0%) | 0% | 65.6 | 107,207 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.28 per share. | 18 Feb 2025 | 17,622 | 119,563 (0%) | 0% | 80.3 | 1,414,694 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 81.00 per share. | 18 Feb 2025 | 700 | 118,863 (0%) | 0% | 81 | 56,700 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 11 Feb 2025 | 13,302 | 142,204 (0%) | 0% | 80 | 1,064,160 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 11 Feb 2025 | 5,019 | 137,185 (0%) | 0% | 80 | 401,520 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 65,033 | 183,896 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.90 per share. | 05 Feb 2025 | 28,390 | 155,506 (0%) | 0% | 80.9 | 2,296,751 | Common Stock |
| Xilio Therapeutics Inc | Sara M. Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| scPharmaceuticals Inc | Sara M. Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 19,750 | 19,750 | - | - | Stock Option (Right to Buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 28 May 2024 | 220,564 | 117,481 (0%) | 0% | 50 | 11,028,200 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.88 per share. | 28 May 2024 | 76,731 | 197,666 (0%) | 0% | 28.9 | 2,215,991 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 76,731 | 11,455 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.46 per share. | 28 May 2024 | 39,446 | 299,594 (0%) | 0% | 26.5 | 1,043,741 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 39,446 | 25,740 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. | 28 May 2024 | 32,156 | 358,769 (0%) | 0% | 17.1 | 548,903 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 32,156 | 59,350 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.70 per share. | 28 May 2024 | 27,074 | 228,194 (0%) | 0% | 24.7 | 668,728 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 27,074 | 4,362 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.03 per share. | 28 May 2024 | 25,046 | 256,694 (0%) | 0% | 34.0 | 852,315 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 25,046 | 17,100 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 28 May 2024 | 20,724 | 338,045 (0%) | 0% | 50.0 | 1,036,407 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.43 per share. | 28 May 2024 | 20,111 | 323,159 (0%) | 0% | 26.4 | 531,534 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 20,111 | 39,275 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.70 per share. | 28 May 2024 | 3,454 | 201,120 (0%) | 0% | 24.7 | 85,314 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.88 per share. | 28 May 2024 | 3,454 | 120,935 (0%) | 0% | 28.9 | 99,752 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.46 per share. | 28 May 2024 | 3,454 | 260,148 (0%) | 0% | 26.5 | 91,393 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.03 per share. | 28 May 2024 | 3,454 | 231,648 (0%) | 0% | 34.0 | 117,540 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 88,186 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. | 28 May 2024 | 3,454 | 326,613 (0%) | 0% | 17.1 | 58,960 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.43 per share. | 28 May 2024 | 3,454 | 303,048 (0%) | 0% | 26.4 | 91,289 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 91,506 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 59,386 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 65,186 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 42,146 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 31,436 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 71,160 | 71,160 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 14,518 | 128,569 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.32 per share. | 13 May 2024 | 11,088 | 117,481 (0%) | 0% | 25.3 | 280,748 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.18 per share. | 09 Jan 2024 | 4,497 | 114,051 (0%) | 0% | 29.2 | 131,222 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 63,560 | 63,560 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 12,873 | 118,548 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Bonstein Sara | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Dec 2023 | 13,199 | 105,241 (0%) | 0% | 30 | 395,970 | Common Stock |
| Xilio Therapeutics Inc | Sara Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| scPharmaceuticals Inc | Sara Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 17,300 | 17,300 | - | - | Stock Option (Right to Buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.30 per share. | 15 May 2023 | 2,210 | 119,229 (0%) | 0% | 19.3 | 42,653 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.47 per share. | 15 May 2023 | 1,610 | 117,619 (0%) | 0% | 18.5 | 29,737 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 158,410 | 158,410 | - | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 34,300 | 100,331 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 21,108 | 121,439 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.12 per share. | 10 Jan 2023 | 2,857 | 66,031 (0%) | 0% | 18.1 | 51,769 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 37,760 | 37,760 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 8,232 | 63,823 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 5,065 | 68,888 (0%) | 0% | - | Common Stock | |
| Xilio Therapeutics Inc | Sara Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| scPharmaceuticals Inc | Sara Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 16,300 | 16,300 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.51 per share. | 16 May 2022 | 1,433 | 54,683 (0%) | 0% | 18.5 | 26,525 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 94,960 | 94,960 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 20,137 | 56,116 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.11 per share. | 11 Jan 2022 | 1,154 | 35,979 (0%) | 0% | 25.1 | 28,977 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 62,840 | 62,840 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 13,006 | 37,133 (0%) | 0% | - | Common Stock | |
| scPharmaceuticals Inc | Sara Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 16,300 | 16,300 | - | - | Stock Option (Right to Buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 68,640 | 68,640 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 14,172 | 23,355 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 45,600 | 45,600 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 9,183 | 9,183 (0%) | 0% | - | Common Stock |